Betamethasone sodium phosphate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for betamethasone sodium phosphate and what is the scope of freedom to operate?
Betamethasone sodium phosphate
is the generic ingredient in two branded drugs marketed by Watson Labs and Schering, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There are seven drug master file entries for betamethasone sodium phosphate.
Summary for betamethasone sodium phosphate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Drug Master File Entries: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 14 |
Patent Applications: | 5,664 |
DailyMed Link: | betamethasone sodium phosphate at DailyMed |
Recent Clinical Trials for betamethasone sodium phosphate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Affiliated Hospital of Nantong University | N/A |
University of Southern California | Phase 4 |
Surface Pharmaceuticals, Inc. | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for betamethasone sodium phosphate
US Patents and Regulatory Information for betamethasone sodium phosphate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | CELESTONE | betamethasone sodium phosphate | INJECTABLE;INJECTION | 017561-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | BETAMETHASONE SODIUM PHOSPHATE | betamethasone sodium phosphate | INJECTABLE;INJECTION | 085738-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |